COVID-19: UK 1st Country Approved Pfizer’s vaccine

COVID-19: UK 1st Country Approved Pfizer’s vaccine. UK urgently authorized Pfizer’s COVID-19 vaccine to be marketed, becoming the first country in the world to be approved

According to the Guardian, the UK became the first Western country to license the COVID-19 vaccine. Prior to the approval of the United States and the European Union, the Medicines and Healthcare Products Administration (MHRA) of the United Kingdom urgently authorized the use of the COVID-19 vaccine developed by Pfizer and BioNTech in just one week, opening the way for mass immunization of high-risk groups.

British Health Minister Matt Hancock said that Britain and Pfizer reached an agreement of 40 million doses. The delivery of Pfizer vaccine will be carried out in phases from 2020 to 2021 to ensure a fair distribution of vaccines in different regions. The United Kingdom will receive 10 million doses this year and will arrive in the next few days.

Albert Bourla, Chairman and CEO of Pfizer, said that the emergency use authorization in the United Kingdom marked a historic moment in the fight against COVID-19, and Pfizer appreciated the timely action of MHRA. With thousands of people being infected every day, every day in this global battle against a severe epidemic is critical. Pfizer expects to obtain further authorizations and approvals and is committed to supplying safe and high-quality vaccines worldwide.

BioNTech CEO and co-founder Ugur Sahin said that our goal is to bring a safe and effective vaccine to all people in need after approval. The data we submit to regulatory agencies around the world is a scientifically rigorous and highly ethical research result. The emergency use authorization in the UK means that people outside of clinical trials have the first opportunity to be vaccinated, which will effectively reduce the risk of hospitalization for high-risk groups.

Pfizer said that in 2020, the company has the ability to supply 50 million doses of vaccine globally, and 1.3 billion doses will be provided by the end of 2021.

With the exception of the United Kingdom, the United States has ordered 100 million doses, while Europe has ordered 200 million doses, which is expected to be approved within a few weeks.